A Case of Kaposi's Sarcoma Treated with Paclitaxel.
- Author:
Hye One KIM
1
;
Bo Hyun LEE
;
Hee Jin HAN
;
Chun Wook PARK
;
Cheol Heon LEE
;
Jung Han KIM
Author Information
1. Department of Dermatology, College of Medicine, Hallym University, Seoul, Korea. dermap@paran.com
- Publication Type:Case Report
- Keywords:
Kaposi's sarcoma;
Paclitaxel
- MeSH:
Aged;
Analgesics;
Biopsy;
Female;
Humans;
Lower Extremity;
Organ Transplantation;
Osteoarthritis;
Paclitaxel*;
Sarcoma, Kaposi*;
Skin;
Stomach;
Transplants;
Viscera
- From:Korean Journal of Dermatology
2005;43(8):1119-1123
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Kaposi's sarcoma (KS) is an angioproliferative disease of the skin and viscera, with the multifactorial origin arising in different clinic-epidemiologic forms. We report a case of a patient with generalized cutaneous and visceral KS, which was successfully treated with paclitaxel. A 78-year-old woman presented with a 2-month history of multiple purpuric nodules and plaques of Kaposi's sarcoma on the face, trunk, and lower extremities. She had not acquired an immunodeficiency syndrome or undergone organ transplantation, but had suffered with osteoarthritis and had taken unknown medication the year prior to presentation. Oral analgesics had also been used as required. Biopsies of both skin and stomach mucosal lesion confirmed KS. The patient was treated with bi-weekly doses of paclitaxel for 5 months. 6 months after the treatment course, histopathological findings on the resolving lesion showed no evidence of Kaposi's sarcoma.
